Type I hypersensitivity

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Type I hypersensitivity | |
|---|---|
| File:2228 Immune Hypersensitivity new (cropped).jpg | |
| Synonyms | Immediate hypersensitivity |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Urticaria, angioedema, anaphylaxis, asthma, allergic rhinitis |
| Complications | Anaphylactic shock, asthma exacerbation |
| Onset | Seconds to minutes after exposure to allergen |
| Duration | Variable, can be chronic with repeated exposure |
| Types | N/A |
| Causes | Allergen exposure (e.g., pollen, dust mites, food allergens, insect stings) |
| Risks | Atopy, family history of allergies |
| Diagnosis | Skin prick test, serum IgE testing |
| Differential diagnosis | Type II hypersensitivity, Type III hypersensitivity, Type IV hypersensitivity |
| Prevention | Avoidance of known allergens, immunotherapy |
| Treatment | Antihistamines, corticosteroids, epinephrine for severe reactions |
| Medication | Antihistamines, corticosteroids, epinephrine |
| Prognosis | N/A |
| Frequency | Common, varies by population and region |
| Deaths | Can be fatal if not treated promptly, especially in cases of anaphylaxis |
Type I hypersensitivity, also known as immediate hypersensitivity, is an allergic reaction provoked by re-exposure to a specific type of antigen referred to as an allergen. This reaction is mediated by immunoglobulin E (IgE) antibodies and is characterized by rapid onset, typically occurring within minutes of exposure to the allergen.
Mechanism[edit]
Type I hypersensitivity involves a two-phase process:
Sensitization[edit]
During the initial exposure to an allergen, the immune system responds by producing IgE antibodies specific to that allergen. These IgE antibodies bind to FcεRI receptors on the surface of mast cells and basophils. This process is known as sensitization.
Re-exposure[edit]
Upon subsequent exposure to the same allergen, the allergen cross-links the IgE antibodies on the surface of mast cells and basophils, triggering these cells to degranulate. This degranulation releases various mediators, including histamine, leukotrienes, and prostaglandins, which lead to the symptoms of an allergic reaction.
Symptoms[edit]
The symptoms of Type I hypersensitivity can vary depending on the route of exposure and the individual. Common symptoms include:
- Urticaria (hives)
- Rhinitis (runny nose)
- Asthma
- Anaphylaxis, a severe, life-threatening reaction
Examples[edit]
Common examples of Type I hypersensitivity reactions include:
Diagnosis[edit]
Diagnosis of Type I hypersensitivity typically involves:
Treatment[edit]
Treatment options for Type I hypersensitivity include:
- Avoidance of known allergens
- Antihistamines
- Corticosteroids
- Epinephrine for anaphylaxis
- Allergen immunotherapy
Also see[edit]
| Lymphocytic adaptive immune system and complement | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|